Considerable interest is being directed toward combining immune-checkpoint inhibition (ICI)
with radiotherapy to improve response rates to ICI, which have been disappointingly low at …

Radiotherapy is used in the treatment of approximately 50% of all malignancies including
gastrointestinal cancers. Radiation can be given prior to surgery (neoadjuvant radiotherapy) …

Background: Immune checkpoint inhibitors (ICI) have represented a revolution in the
treatment of non-small-cell lung cancer (NSCLC). To improve these results, combined …

Stereotactic body radiation therapy (SBRT) offers excellent local control of early-stage non-
small cell lung cancer (NSCLC), but there currently is a need for tolerable systemic therapy …

Lung cancer is one of the main causes of cancer-related mortality worldwide. Over the years,
different therapeutic modalities have been adopted depending on tumor stage and patient …

Immune checkpoint inhibitors have emerged as a breakthrough therapy in the treatment in
various metastatic cancers. In parallel, the role of radiotherapy in metastatic cancers has …

Immunotherapy-based combinations: an update : Current Opinion in Oncology
Immunotherapy-based combinations: an update : Current Opinion in Oncology Log in or …

Abstract Purpose of Review The purpose of this paper is to review all recent and relevant
data regarding the combined use of immunotherapy (particularly immune checkpoint …

Most patients treated for differentiated thyroid cancer (DTC) fare quite well. Data from the
Surveillance, Epidemiology, and End Results (SEER) program show that 98.1% of patients …

The understanding of localized radiation therapy's immunostimulatory properties combined
with its well-known effects on the cell cycle and insights into the immunomodulation …